Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8209415rdf:typepubmed:Citationlld:pubmed
pubmed-article:8209415lifeskim:mentionsumls-concept:C1280551lld:lifeskim
pubmed-article:8209415lifeskim:mentionsumls-concept:C0010287lld:lifeskim
pubmed-article:8209415lifeskim:mentionsumls-concept:C1552617lld:lifeskim
pubmed-article:8209415lifeskim:mentionsumls-concept:C0282443lld:lifeskim
pubmed-article:8209415pubmed:issue5lld:pubmed
pubmed-article:8209415pubmed:dateCreated1994-7-8lld:pubmed
pubmed-article:8209415pubmed:abstractTextIn the dog, creatine kinase (CK) is mostly present in the skeletal muscles, myocardium, brain and intestine. The MM isoenzyme predominates in muscles and myocardium. In plasma, reference values depend on the technique used and CK-MB accounts for about 30-45% of total CK activity. Sex has no influence on plasma CK activity, which is higher in young dogs than in adults. Plasma CK is elevated after physical exercise. After its release from the cells, CK reaches the plasma mostly via the lymphatic route and then remains in the plasma compartment. It is rapidly cleared with a half-life of about 2 hours. Muscle diseases are the main source of plasma CK elevations: inherited myopathies, malignant hyperthermia, hypothyroidism, vitamin E-selenium deficiency, prolonged decubitus, intramuscular injections, surgery, etc. Plasma CK is also increased in experimental myocardial infarction, for which the dog is an interesting model, allowing quantification of the damage by measuring the total CK activity released.lld:pubmed
pubmed-article:8209415pubmed:languageenglld:pubmed
pubmed-article:8209415pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8209415pubmed:citationSubsetIMlld:pubmed
pubmed-article:8209415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8209415pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8209415pubmed:statusMEDLINElld:pubmed
pubmed-article:8209415pubmed:issn0165-7380lld:pubmed
pubmed-article:8209415pubmed:authorpubmed-author:BraunJ PJPlld:pubmed
pubmed-article:8209415pubmed:authorpubmed-author:ToutainP LPLlld:pubmed
pubmed-article:8209415pubmed:authorpubmed-author:LefebvreH PHPlld:pubmed
pubmed-article:8209415pubmed:authorpubmed-author:AktasMMlld:pubmed
pubmed-article:8209415pubmed:authorpubmed-author:AugusteDDlld:pubmed
pubmed-article:8209415pubmed:issnTypePrintlld:pubmed
pubmed-article:8209415pubmed:volume17lld:pubmed
pubmed-article:8209415pubmed:ownerNLMlld:pubmed
pubmed-article:8209415pubmed:authorsCompleteYlld:pubmed
pubmed-article:8209415pubmed:pagination353-69lld:pubmed
pubmed-article:8209415pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:meshHeadingpubmed-meshheading:8209415-...lld:pubmed
pubmed-article:8209415pubmed:year1993lld:pubmed
pubmed-article:8209415pubmed:articleTitleCreatine kinase in the dog: a review.lld:pubmed
pubmed-article:8209415pubmed:affiliationDepartment of Physiopathology, Ecole Nationale Vétérinaire, Toulouse, France.lld:pubmed
pubmed-article:8209415pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8209415pubmed:publicationTypeReviewlld:pubmed